Details for New Drug Application (NDA): 219106
✉ Email this page to a colleague
The generic ingredient in VARENICLINE TARTRATE is varenicline tartrate. There are twelve drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the varenicline tartrate profile page.
Summary for 219106
| Tradename: | VARENICLINE TARTRATE |
| Applicant: | Regcon Holdings |
| Ingredient: | varenicline tartrate |
| Patents: | 0 |
Pharmacology for NDA: 219106
| Mechanism of Action | Cholinergic Agonists Partial Cholinergic Nicotinic Agonists |
Medical Subject Heading (MeSH) Categories for 219106
Suppliers and Packaging for NDA: 219106
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 219106 | ANDA | Indoco Remedies Limited | 14445-153 | 14445-153-56 | 56 TABLET, FILM COATED in 1 BOTTLE (14445-153-56) |
| VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 219106 | ANDA | Indoco Remedies Limited | 14445-154 | 14445-154-02 | 1 BLISTER PACK in 1 CARTON (14445-154-02) / 56 TABLET, FILM COATED in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 0.5MG BASE | ||||
| Approval Date: | Oct 29, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
| Approval Date: | Oct 29, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
